There are a number of palliative treatments avail-
able, each with advantages and disadvantages. Surgery probably provides the best palliation if the patient is fit enough, but the mortality and morbidity can be high.' Radiotherapy with current techniques has a low mortality, but prolonged morbidity, and slow relief of dysphagia.l Repeated bougienage becomes an increasing burden and as the disease progresses is more difficult, more painful and provides less benefit for shorter intervals each time. 4 Chemotherapy has only a small part to play at present in the treatment of oesophageal cancer, although some responses have been reported with cisplatin.5 A gastrotomy tube provides a route for nourishment, but does not help dysphagia. For patients who are unfit for major surgery, the most effective established technique for relieving obstruction is insertion of a prosthetic tube, although many question the quality of the palliation achieved.' In 1982 Fleischer first Bowaw, Hawes, Mattliewson, Swain, Bairr, Bolalos, (t11( (ltark swallowing ability in the majority of patients and have been relatively consistent with regards to the choice of patient groups, laser parameters used, immediate clinical benefits, and acute complication rate. Reports to date have dealt primarily with the results of the first laser course, however, with few reporting long term follow up in any detail, particularly the incidence of recurrent dysphagia and its subsequent management. The purpose of this paper is to present the results of both initial laser treatment and subsequent follow up to identify how this new treatment can be applied most effectively to give good and prolonged palliation with a minimum of general upset to these patients who have such a limited life expectancy.
Methods

PATIENTS
The study group consisted of 34 consecutive patients treated at University College Hospital, London for whom detailed follow up data were available. There were 27 men and seven women with a mean age of 71 years (range 52-88). All had dysphagia caused by advanced malignant disease of the oesophagus or gastric cardia that was considered incurable at the time of referral. The mean tumour length was 8-0 cm (range 3-15 cm). Histologically, 12 were squamous and 22 adenocarcinomas. Three (9°/.) were cervical (origin at 15-22 cm), 14 (41% ) were mid-oesophageal (origin 23-34 cm) and 17 (50(%) started in the distal oesophagus or gastric cardia (origin below 34 cm). Eight patients were considered unfit for surgery or radiotherapy because of the advanced state of their malignancy, and 12 others were considered unfit because of other serious pathology (mostly cardiorespiratory disease). Six had undergone operation with a view to resection, but not only had the tumour proved too advanced to resect, but dilatation of the stenosis adequate to insert a prosthetic tube had proved impossible. Two had previously had a prosthetic tube inserted but discomfort from the tube had been severe enough for the patient to request its removal and seek alternative treatment. Four had anastomotic recurrences after earlier resections of the oesophagus or gastric cardia but were considered unfit for further surgery, one had tumour overgrowing a Celestin tube and one refused surgery.
ENDOSCOPIC TECHNIQUE
All procedures were performed using a 100 watt Nd YAG laser (Fiberlase 100, Pilkington Medical Systems Ltd, Glasgow). The laser light is delivered through a single flexible fibre (0.4 mm diameter) enclosed in a Teflon sheath (2.3 mm diameter) through which coaixial carbon dioxide gas is delivered. The gas serves to cool the fibre tip and prevents debris from sticking. This catheter system is passed down the biopsy channel of a standard flexible gastroscope fitted with an appropriate safety filter in the eyepiece. A small nasogastric tube is placed alongside the endoscope into the proximal oesophagus during treatment and attached to a chest drain bottle. This system allows the carbon dioxide gas to escape thus preventing overdistension of the viscus, and it also traps the smoke produced making the environment more pleasant for the patient and staff. Patients were sedated with intravenous diazemuls (5-10 mg) sometimes with the addition of pethidine (25-50 mg) . In one patient with a tumour of the cervical oesophagus general anaesthesia was used.
The tip of the fibre was held 5-10[mm from the target (always avoiding tissue contact) with power settings ranging between 60-80 watts and shots of one second duration.
The aim was to destroy as much intraluminal tumour as could be done safely. Some tissue vaporised immediately with each laser shot while adjacent areas were necrosed and either sloughed over a few days or healed with fibrosis. Treatment was directed at the parts of the tumour causing the worst obstruction and proceeded to shave the occluding nodules back towards, but not quite as far as, the normal oesophageal wall. Whenever possible, treatment started at the distal margin of the tumour because immediate oedema in unvaporised areas after therapy could hinder progress in the opposite direction. In some cases, the endoscope could not be negotiated past the lesion initially, even after dilatation, and treatment had to start proximally. With tight stenoses, immediate oedema was reduced by lowering the laser power to about 15 W and fitting a sapphire tip to the laser fibre (Surgical Laser Technologies, Keighley). This can be used in direct contact with tissue and acts like a hot knife.' All accessible tumour was treated at each session, and treatment repeated at intervals of three to four days (to allow necrosed tumour to slough) until full recanalisation was achieved. The early cases were followed up as outpatients, and endoscopy repeated if dysphagia recurred, although more recently our policy has changed, and all patients now have repeat endoscopies three to four weeks after the initial course of treatment to assess the result and treat remaining intraluminal tumour if required. For those with recurrent dysphagia, subsequent management depended on the endoscopic findings. Those with recurrent exophytic tumour were treated with the laser again, whereas those without obvious endoscopically accessible tumour were treated by dilatation and insertion of a Celestin tube.
Endoscopic laserpalliationfor advanced malignant dysphagia Table 2 and of the five failures of initial laser treatment in Table 3 . An overall summary of patient care is shown in Figure 1 (Fleischer 14 weeks,' Mellow 21 weeks'4 and after intubation (Ogilvie 24 weeks)"').
Laser therapy aims to debulk intraluminal tumour, and is only possible if the main bulk causing obstruction is exophytic and endoscopically accessible. This is the case for most primary tumours of the oesophagus, although is rarely so for tumours compressing or invading the oesophagus from outside the lumen. The latter together with those that have developed a spontaneous perforation or tracheooesophageal fistula can only be helped by intubation. It may be possible to treat submucosal tumours if their extent is precisely defined by computed tomography scans or endoscopic ultrasound, but this requires burning through normal mucosa to gain access to the tumour and carries a higher risk of perforation.'7 The laser has the advantage that no foreign body is left in the gastrointestinal tract, and can be used in the cervical oesophagus where a tube could not be tolerated.
Insertion of a tube with the aid of a guide wire is usually technically straightforward although it can be uncomfortable for the patient unless general anaesthesia is used. In some patients, however, tortuosity of the stenosed oesophageal lumen makes insertion of the guide wire impossible. The high incidence of this in this series (seven cases, in four of whom the wire could not even be inserted at an open surgical procedure) reflects selective referral of intubation failures, and is a good indication for laser treatment, as successful recanalisation was achieved in five of the seven. Intubation has the advantage of only requiring one endoscopy, whereas laser recanalisation requires several and on average, each patient in this series required 2 7 sessions for recanalisation, spread over nine days. However, with increasing experience few patients now require more than two treatments initially and with twice weekly endoscopy. this means that the course can be finished in less than a week. Patients who are otherwise well enough can be treated als day cases. The time in hospital for the later cases in our series now compares favourably with the average of five days reported for uncomplicated intubations." Second and subsequent laser courses were even shorter ( yet to be fully assessed for oesophageal lesions. For some patients, the hospital stay is longer because their general condition is poor and suitable arrangements must be made for their care at home, but these are social factors which do not depend on the method of treatment used.
The only major complications related to laser treatment were two perforations (6%) both of which occurred during an initial course of treatment. One was fatal. One occurred very early in the series during the fifth treatment in a patient with a 13 cm tumour, and perhaps reflected inexperience in a difficult situation. He did well after a surgical gastric pull-up procedure. The second had a total obstruction at the cardia which prevented passage of a guide wire more than cm below the lumen visualised endoscopically. This was recognised to be an extremely high risk situation, but as there were no reasonable alternatives, he was treated blindly with a sapphire tipped probe. He sustained a perforation and died a few days later. This technique was used successfully in another similar patient, however, presenting with complete obstruction and no identifiable lumen. After treatment the patient could swallow semisolids, and lived comfortably at home for a further 20
weeks. This incidence of perforation is comparable with that of other series [Fleischer 5%, 17 Delvaux (in a multicentre review) 4%1I9. These larger series identified further risk factors such as previous radiotherapy, acute angulation in a tumour at the cardia, and bougienage at the same session as laser treatment. The risk of perforation, however, should be kept very low if one is aware of these. Bougienage makes it possible to reduce the number of endoscopies required by improving endoscopic access and is a most useful technique if appropriately employed, although some authors prefer to avoid its use.' The incidence of perforation after intubation is higher at 9-11%.2" The mortality from procedure related complications is 2-16% after intubation 2 1( 20121but only 1-5% after laser.9 1119
The quality of swallowing is notoriously difficult to quantify as it is difficult to assess objectively. The best simple approach is to use the five grades shown in Figure 2 . With a prosthetic tube in place there is inevitably a rigid section of the oesophagus through which food must pass solely under the influence of gravity. With commercially available tubes, this is typically 11-12 mm in diameter and 10-12 cm long. Swallowing in these patients is helped by frequent s ;olds sips of carbonated drinks, the bubbles acting as a lubricant. In Ogilvie's series, 58% could swallow most solids and a further 8% all solids after intubation'" but it is doubtful if any of these individuals could adopt entirely normal eating habits without a risk of tube blockage. Watson reported that only 33% could take solids after intubation. Some further improvement may be possible by using tubes tailor made for individual tumours,2 but there must always be a rigid section of the oesophageal wall.
The quality of swallowing after laser treatment is more variable, as it depends on the nature and extent of the diseased areas of oesophagus remaining. If the tumour is not circumferential, then it may be possible for peristaltic waves to pass the full length of the organ, and if exophytic tumour has been cleared, swallowing can be close to normal. It would be difficult to do better than one of our patients who commented that nine months after treatment he felt the occasional piece of steak catch on something as it went down. A long and circumferential lesion may develop into a rigid, aperistaltic tube after therapy, however, with the same functional result as a prosthetic tube. Twelve of our patients (35%) ate a normal diet after treatment and a further 13 (38%) could swallow most solids, although some commented that they had to eat slowly. These results are very similar to Mellow and Pinkas' figures of 43% and 33% respectively.9
There are some patients who have continuing dysphagia after treatment despite re-establishment of luminal patency. This occurs particularly with high cervical lesions after previous radiotherapy (perhaps because of damage to pharyngeal muscles). Severe pretreatment anorexia, in contrast with the dysphagia, seldom responds to endoscopic treatment. 9 Thus overall, about one third of patients are restored to an eating pattern close to normal and probably better than anything that can be achieved by intubation, and another third can eat most solids, comparable with those with a tube. Fleischer6 reports results equivalent to these two groups of ours in 48 of 60 patients (80%), Mellow'4 in eight of 10 (80%) and Riemann"' in 14 of 18 (78%). Nevertheless, a true comparison of the quality of swallowing after intubation or laser treatment can only come from a randomised, controlled trial. One such trial has been reported, which suggested that swallowing was better after laser therapy, although the total number of patients included was only 20. 23 The value of palliation for malignant dysphagia depends not only on the immediate result of treatment, but on the period for which symptomatic benefit persists and the need for subsequent intervention to treat recurrence. This aspect is poorly covered in most of the reports of endoscopic therapy so far published. In Ogilvies series,'" of the 102 patients discharged after successful intubation, 51 (50%) had recurrent dysphagia or late procedure related complications. Eighteen had blocked tubes, 17 had displaced or damaged tubes and in seven the tumour grew over the tube. All these were treated by unblocking or replacing the tube except three of the tumour overgrowths. Nine patients died from late perforations because of pressure necrosis from the tube. In our series there were no late deaths related to the initial procedure but of the 28 patients who had a first successful course of laser treatment without any other immediate therapy, 18 (64%) required subsequent intervention (four patients who have received only one laser course are still alive, and so could yet develop further dysphagia). Although 10 of these with recurrence did well after further laser treatment, eight had no exophytic tumour at repeat endoscopy and needed alternative therapy (Table 2) . These results are compared with those in other series in Table 4 . The need for further intervention and the use of further laser treatment or intubation are similar. In the present series, however, the fact that those who had further laser treatment did so after a mean of five weeks whereas those needing alternative later intervention did so after a mean of 10 weeks suggests that the former group may have had inadequate laser treatment in the first course. The longer 
